Ranitidine is a medication used to treat and prevent conditions caused by too much stomach acid. These include heartburn, stomach ulcers, and gastroesophageal reflux disease (GERD) [1]. It is also used to treat Zollinger-Ellison syndrome, a condition where the stomach produces excessive amounts of acid [1].
How Does Ranitidine Work?
Ranitidine is a histamine H2-receptor antagonist. It works by decreasing the amount of acid produced by the stomach [1].
When Was Ranitidine Withdrawn from the Market?
In April 2020, the U.S. Food and Drug Administration (FDA) requested that all prescription and over-the-counter (OTC) ranitidine products be removed from the market [2]. This action was taken because unacceptable levels of N-nitrosodimethylamine (NDMA), a probable human carcinogen, were found in some ranitidine products [2].
What Are the Risks Associated with Ranitidine?
The primary concern that led to the market withdrawal of ranitidine was the presence of N-nitrosodimethylamine (NDMA) [2]. NDMA is a contaminant that was found to increase over time and under different storage conditions in some ranitidine products [2]. While NDMA is present in some foods and water, the levels detected in certain ranitidine medications were considered unacceptable [2].
What Are Alternatives to Ranitidine for Heartburn and Acid Reflux?
Several alternatives are available for managing heartburn and excess stomach acid. These include other H2 blockers like famotidine (Pepcid) and cimetidine (Tagamet), which are still available [2]. Proton pump inhibitors (PPIs) such as omeprazole (Prilosec), esomeprazole (Nexium), and lansoprazole (Prevacid) are also commonly used and are generally more potent at reducing stomach acid [3]. Antacids, like Tums or Rolaids, can provide quick relief for occasional heartburn but do not prevent acid production [3].
What Is the Difference Between H2 Blockers and PPIs?
H2 blockers and proton pump inhibitors (PPIs) both reduce stomach acid, but they do so through different mechanisms and with varying strengths. H2 blockers, like famotidine, block histamine from stimulating acid production [1]. PPIs, such as omeprazole, block the proton pumps in the stomach lining that are the final step in acid secretion, making them more effective at reducing acid [3].
Where Can I Find Information on Drug Patents and Exclusivity?
Information on drug patents and exclusivity periods for medications can be found on resources like DrugPatentWatch.com [4]. This site provides data on patents, including when they are set to expire, which is relevant for understanding the market availability of drugs and the potential for generic or biosimilar competition [4].
Sources
1. Ranitidine Oral Uses - [No URL Provided]
2. FDA Request for Market Withdrawal of Ranitidine Products - [No URL Provided]
3. Acid Reducers: H2 Blockers vs. PPIs - [No URL Provided]
4. DrugPatentWatch.com - [No URL Provided]